Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury
Antioxidants & Redox Signaling · 2025
DOI: 10.1177/15230864251369883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2025. Verfasst von Yulu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Iron, Proto-Oncogene Proteins c-myc, DEAD Box Protein 58. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Aims
Iron metabolism disorders are critical in the pathogenesis of acute kidney ischemia-reperfusion injury (IRI). However, the molecular mechanisms driving these disturbances remain poorly understood.
Results
In IRI mouse kidneys, pathological alterations, iron metabolism disruptions, and functional impairments were observed. Retinoic acid-inducible gene-I (RIG-I), transcription factor c-Myc, and ferritin heavy chain (FTH) exhibited elevated expression and colocalization in tubular epithelial cells, accompanied by decreased glutathione peroxidase 4 (GPX4) level and evidence of ferroptosis. Further in vitro studies revealed that RIG-I promoted c-Myc activation. The latter demonstrated its positive regulation of FTH transcription by chromatin immunoprecipitation assays and c-Myc siRNA experiments. Interestingly, FTH overexpression resulted in elevated levels of RIG-I, transferrin receptor, ferroportin, and nuclear receptor coactivator 4. Ultimately, the c-Myc inhibitor 10058-F4 reversed all adverse alterations and demonstrated a protective role in IRI mouse kidneys and mouse kidney tubule cells subjected to the ferroptosis inducer erastin, RIG-I agonist, or hypoxia/reoxygenation. This reversal was reflected in improved renal morphology and function, balanced iron metabolism, increased GPX4 level, decreased 4-hydroxynonenal level, reduced inflammatory cell infiltration, interleukin-1 beta release, and kidney injury molecule 1 expression. Innovation: This study proposes a novel mechanism in which c-Myc is activated by elevated RIG-I in IRI kidneys and positively regulates FTH transcription, therefore involving iron metabolism disorders.
Conclusions
The RIG-I, c-Myc, and FTH disrupt iron homeostasis, and the c-Myc inhibition stabilizes iron metabolism and mitigates oxidative stress, suggesting a potential therapeutic target in IRI. Antioxid. Redox Signal. 43, 622–636.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Basic Medical College, China Medical University, Shenyang, China.
- Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.
- Institute of Nephropathology, Basic Medical College, China Medical University, Shenyang, China.
- Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Obstetrics and Gynaecology, Shenyang Women and Children's Hospital, Shenyang, China.
- The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
ORCID-Profile: Yulu Zhang
Zitieren
APA
Zhang, Y., Xing, J., Yao, L., Zou, Y., Peng, H., Yi, X., Bai, L., Yu, Y., Liu, H., Li, X., & Zhai, X. (2025). Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864251369883
Vancouver
Zhang Y, Xing J, Yao L, Zou Y, Peng H, Yi X, et al. Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. 2025. doi:10.1177/15230864251369883
BibTeX
@article{Zhang2025,
author = {Zhang, Yulu and Xing, Jia and Yao, Li and Zou, Yu and Peng, Hui and Yi, Xiling and Bai, Lifang and Yu, Yang and Liu, Hanzhe and Li, Xue and Zhai, Xiaoyue},
title = {Reprogramming Iron Metabolism via the RIG-I/c-Myc/FTH Axis Mitigates Renal Ischemia-Reperfusion Injury},
journal = {Antioxidants & Redox Signaling},
year = {2025},
doi = {10.1177/15230864251369883}
}
EUVIMED